Core Viewpoint - The company reported a significant decline in financial performance for the fiscal year 2025, with a notable drop in both revenue and net profit compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 384.48 million, representing a year-on-year decrease of 13.07% [1] - The net profit attributable to shareholders was -3.54 million, reflecting a year-on-year decline of 109.81% [1] - Operating profit decreased by 110.08% compared to the same period last year [1] - Total profit fell by 112.21% year-on-year [1] - Basic earnings per share decreased by 108.70% compared to the previous year [1] Contributing Factors - The gross profit margin was approximately 60%, which, despite an increase from the previous year, was impacted by reduced capital expenditures from operators, leading to a decline in revenue [1] - The issuance of convertible bonds resulted in an increase in interest expenses by approximately 9 million year-on-year [1] - Research and development expenses increased by about 10.90 million compared to the previous year due to heightened investment [1] - The implementation of an employee stock ownership plan and restricted stock incentives led to a corresponding share-based payment expense of approximately 3 million [1]

Financial Performance - The company reported total revenue of 384.48 million yuan for 2025, a decrease of 13.07% compared to the previous year[8] - The net profit attributable to shareholders was -3.54 million yuan, representing a decline of 109.81% year-over-year[8] - The basic earnings per share fell to -0.02 yuan, a decline of 108.70% compared to the previous year[7] Assets and Equity - The company's total assets increased by 15.85% to 1,613.85 million yuan at the end of 2025[8] - The equity attributable to shareholders decreased by 0.70% to 1,034.12 million yuan[8] Profitability Metrics - The weighted average return on equity decreased by 3.83 percentage points to -0.33%[7] - The gross profit margin was approximately 60%, which improved compared to the previous year, but revenue declined due to reduced capital expenditures from operators[9] Research and Development - Research and development expenses increased by approximately 10.90 million yuan year-over-year, reflecting the company's commitment to innovation[9] Financial Instruments and Expenses - The company issued convertible bonds in 2025, leading to an increase in interest expenses by about 9 million yuan[9] - The company implemented an employee stock ownership plan, resulting in share-based payment expenses of approximately 3 million yuan[9]

Core Viewpoint - On February 23, a total of 34 listed companies had their restricted shares unlocked, with a total market value of approximately 19.007 billion yuan [1] Group 1: Restricted Share Unlocking Details - Luzhou Laojiao (000568) had 2.0425 million shares unlocked under equity incentive restrictions - AVIC Xi'an Aircraft Industry (000768) had 4.3606 million shares unlocked under equity incentive restrictions - Hubei Energy (000883) had 19.2779 million shares unlocked under equity incentive restrictions - Jining Pharmaceutical (000919) had 1.92 million shares unlocked under equity incentive restrictions - Guangji Pharmaceutical (000952) had 2.5209 million shares unlocked under equity incentive restrictions - China Software (600536) had 57,200 shares unlocked under equity incentive restrictions - Xinhua Medical (600587) had 1.7845 million shares unlocked under equity incentive restrictions - Baoxin Software (600845) had 10.2578 million shares unlocked under equity incentive restrictions - China Railway (601390) had 55.9338 million shares unlocked under equity incentive restrictions - China Communications Construction (601800) had 5.593 million shares unlocked under equity incentive restrictions - StarNet Ruijie (002396) had 2.8342 million shares unlocked under equity incentive restrictions - Lopuskin (002333) had 22.3212 million shares unlocked under A-share issuance to legal persons - Wanbangda (300055) had 33.6538 million shares unlocked under A-share issuance to legal persons - Hangyang Co., Ltd. (002430) had 5.2049 million shares unlocked under equity incentive restrictions - Taijia Co., Ltd. (002843) had 949,600 shares unlocked under equity incentive restrictions - Nanda Optoelectronics (300346) had 130,000 shares unlocked under equity incentive restrictions - Anhui Natural Gas (603689) had 2.5064 million shares unlocked under equity incentive restrictions - Zhongyan Dadi (003001) had 97,200 shares unlocked under equity incentive restrictions - Yuanxiang New Materials (301300) had 30.2983 million shares unlocked with extended lock-up period - Yidao Information (001314) had 88.6187 million shares unlocked under pre-issuance restrictions - Tongda Electric (603390) had 579,500 shares unlocked under equity incentive restrictions - Yangzhou Jinqiao (603307) had 50 million shares unlocked under pre-issuance restrictions - Aili Home (603221) had 2.29 million shares unlocked under equity incentive restrictions - Zhili Fang (301312) had 333,900 shares unlocked under equity incentive restrictions - Kuntai Co., Ltd. (001260) had 83.25 million shares unlocked under pre-issuance restrictions - Entropy Technology (301330) had 92.5223 million shares unlocked with extended lock-up period - Yatong Precision (603190) had 596,100 shares unlocked under pre-issuance restrictions - Sanwang Communication (688618) had 87,400 shares unlocked - Longxun Co., Ltd. (688486) had 30.6312 million shares unlocked - Dize Pharmaceutical (688192) had 991,100 shares unlocked - Haohan Depth (688292) had 57.5177 million shares unlocked - Haizheng Biomaterials (688203) had 78.5601 million shares unlocked - Diaomicro (688381) had 55.9536 million shares unlocked - Zhongrun Optics (688307) had 29.8507 million shares unlocked [1]

Group 1 - The core viewpoint of the article highlights the active performance of AI review concepts in the market, with several companies experiencing significant stock price increases [1] - Companies such as People's Daily reached the daily limit increase, while Haohan Deep Technology rose over 10%, and Guotou Intelligent increased by over 8% [1] - Other companies that followed suit include Bohui Keji, Sanwei Xinan, Jida Zhengyuan, and Zhongxin Saike, indicating a broader trend in the sector [1] Group 2 - The news mentions that some online accounts have been disseminating AI-generated synthetic information that misleads the public, damaging the online ecosystem [1] - Regulatory authorities have urged website platforms to conduct thorough investigations and rectify these issues, resulting in the disposal of 13,421 accounts and the removal of over 543,000 pieces of illegal information [1]

Group 1 - The company has issued 3.5429 million convertible bonds with a total amount of 354.29 million yuan, net proceeds amounting to 345.6416 million yuan after deducting related fees [3] - The convertible bonds are listed on the Shanghai Stock Exchange under the name "Hao Han Convertible Bonds" with the code "118052" starting from April 7, 2025 [4] - The initial conversion price for the convertible bonds was set at 24.38 yuan per share, which was adjusted to 24.26 yuan per share due to the company's annual equity distribution plan [6][7] Group 2 - The conversion period for the bonds is from September 19, 2025, to March 12, 2031 [5] - The company has the right to redeem the bonds at 115% of the face value within five trading days after the maturity if they remain unconverted [9] - Conditional redemption can occur if the stock price remains at or above 130% of the conversion price for at least 15 out of 30 consecutive trading days, or if the unconverted balance is less than 30 million yuan [9][10] Group 3 - As of January 14, 2026, the company's stock price has been above 31.54 yuan per share (130% of the conversion price) for 10 trading days, indicating a potential trigger for the conditional redemption clause [10] - The company will convene a board meeting to decide on exercising the redemption right if the conditions are met and will fulfill disclosure obligations accordingly [11]

| 证券代码：688292 | 证券简称：浩瀚深度 | 公告编号：2026-007 | | --- | --- | --- | | 转债代码：118052 | 转债简称：浩瀚转债 | | 北京浩瀚深度信息技术股份有限公司 关于"浩瀚转债"预计满足赎回条件的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 特别提示： 北京浩瀚深度信息技术股份有限公司（以下简称"公司"）股票自 2026 年 1 月 14 日至 2026 年 2 月 12 日期间，已有 10 个交易日的收盘价格不低于"浩瀚 转债"当期转股价格的 130%（即 31.54 元/股）。根据《北京浩瀚深度信息技术 股份有限公司向不特定对象发行可转换公司债券募集说明书》（以下简称"《募集 说明书》"）中有条件赎回条款的相关规定，如果公司股票连续三十个交易日中至 少有十五个交易日的收盘价格不低于当期转股价格的 130%（含 130%），届时公司 有权决定按照债券面值加当期应计利息的价格赎回全部或部分未转股的"浩瀚转 债"。 本次可转债转股期自本次可转债发行结束 ...

Core Insights - The company has made comprehensive technological layouts and product implementations in AI cybersecurity, deep synthesis content authentication, and AI fraud prevention [2] Group 1: Deep Synthesis Authentication System - The company will officially launch the digital content forgery detection system version 1.0 in June 2024, integrating DPI, multi-modal analysis, and large model training technologies [2] - The system has passed authoritative certification from the China Academy of Information and Communications Technology for 22 types of generative models, receiving national-level recognition [2] - It has already been commercialized in scenarios such as real-name authentication and audio-video communication, effectively preventing risks like false registrations and scam calls [2] - In Q1 2025, the subsidiary Guorui Zhizhi successfully won a bid for an AI authentication platform project from a provincial telecom company, with plans to expand into high-frequency business scenarios like live streaming platform reviews and social media content governance [2] Group 2: Intelligent Fraud Prevention System - The company has constructed a three-in-one intelligent fraud prevention system that integrates "voiceprint-semantics-deep forgery" to address fraud threats posed by AI voice simulation and deep forgery technologies [2] - This system relies on large model technology to accurately analyze dialogue contexts and fraudulent intentions, effectively identifying scams using voice-changing or voice synthesis software [2] Group 3: Multi-Modal Forgery Detection Engine - The company has developed a self-researched multi-modal domain-specific base model that combines image visual feature analysis, voice biometric recognition, and text semantic consistency verification [2] - This technology framework covers audio, video, images, and text for forgery content detection, analyzing the logic and risk assessment methods for deep forgery content from a technical principle perspective [2] Group 4: AI Security Verification and Compliance Supervision - The company is actively laying out in the AI security field, having independently developed a large model security inspection system to support the Ministry of Industry and Information Technology in AI compliance supervision [2] - The company is also deeply involved in the construction of the deep synthesis detection and disposal platform by the Ministry of Industry and Information Technology, enhancing its comprehensive capabilities in data privacy protection and AI risk governance [2] - The related technologies have formed a product matrix, with plans to continue driving business growth through a dual approach of "technology research and development + scenario implementation" [2]

| 证券代码：688292 | 证券简称：浩瀚深度 | 公告编号：2026-006 | | --- | --- | --- | | 转债代码：118052 | 转债简称：浩瀚转债 | | 北京浩瀚深度信息技术股份有限公司 首次公开发行限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 57,517,720股。 本次股票上市流通总数为57,517,720股。 本次股票上市流通日期为2026 年 2 月 24 日（因 2026 年 2 月 18 日为非交 易日，上市流通日顺延）。 一、本次上市流通的限售股类型 经中国证券监督管理委员会《关于同意北京浩瀚深度信息技术股份有限公司 首次公开发行股票注册的批复》（证监许可〔2022〕1233 号）同意公司首次公开 发行股票的注册申请，并经上海证券交易所同意，公司于 2022 年 8 月首次公开发 行人民币普通股（A 股）3,928.6667 万股，每股发行价格 16.56 元。公司已于 2 ...

国金证券股份有限公司 关于北京浩瀚深度信息技术股份有限公司 首次公开发行部分限售股上市流通的核查意见 国金证券股份有限公司（以下简称"国金证券"或"保荐机构"）作为北京 浩瀚深度信息技术股份有限公司（以下简称"浩瀚深度"或"公司"）首次公开 发行股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》等有关规定，对浩瀚深度首次公开发行 部分限售股上市流通事项进行了审慎核查，核查情况及核查意见如下： 一、本次上市流通的限售股类型 经中国证券监督管理委员会《关于同意北京浩瀚深度信息技术股份有限公司 首次公开发行股票注册的批复》（证监许可〔2022〕1233号）同意公司首次公开 发行股票的注册申请，并经上海证券交易所同意，公司于2022年8月首次公开发 行人民币普通股（A股）3,928.6667万股，每股发行价格16.56元。公司已于2022 年8月18日在上海证券交易所科创板上市。首次公开发行后，公司总股本为 15,714.6667万股，其中有限售条件流通股为12,260.8588万股，无限售条件流通股 为3,453.8079万股。 本次上市流通的限售股为公司首次公 ...

Core Viewpoint - Japan's Eisai has entered into a licensing agreement with Shanghai Henlius Biotech for the lung cancer drug Hansizhuang, involving an upfront payment of $75 million and potential milestone payments totaling up to $313.34 million [1] Group 1 - Eisai will pay an upfront fee of $75 million to Henlius for the licensing rights to Hansizhuang [1] - The agreement includes additional milestone payments that could reach up to $313.34 million, contingent on the achievement of specific targets [1] - This partnership highlights the growing collaboration between Japanese and Chinese biopharmaceutical companies in the oncology sector [1]